[Changes in lymphokine-activated killer cell (LAK) activity in patients with hepatocellular carcinoma after transcatheter arterial embolization].
D006528:Carcinoma, Hepatocellular / Q000276:immunology* / Q000628:therapy; D004621:Embolization, Therapeutic; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology*; D008113:Liver Neoplasms / Q000276:immunology* / Q000628:therapy
D007376:Interleukin-2